APO Research
Talk to an analyst

APO RESEARCH · REPORT

Compounding Pharmacy

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:

A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.

A person may be allergic to one of the ingredients in the commercial version of a drug.

A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.

Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.

Selected research

Market Outlook & Growth Opportunities

Global Compounding Pharmacy Market Outlook and Growth Opportunities 2026

21 December 2025218 pages

Choose your research edition.

Industry ResearchCompounding Pharmacy Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Compounding Pharmacy Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Compounding Pharmacy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Compounding Pharmacy Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Compounding Pharmacy Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:

A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.

A person may be allergic to one of the ingredients in the commercial version of a drug.

Read the full market overview

A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.

Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.

Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%.

North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.

This report provides an overview of the global Compounding Pharmacy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Compounding Pharmacy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Compounding Pharmacy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Compounding Pharmacy market.

Compounding Pharmacy Segment by Company

PharMEDium Services

B. Braun Group

Fagron

Wedgewood Pharmacy

New Compounding Pharma

Medisca

Fresenius Kabi

Advanced Pharma

AIN GROUP

Nihon Chouzai

Sogo Medical

Dougherty’s Pharmacy

Apollo Pharmacy

Downing Labs

Qol Holdings

Olympia Pharmacy

PUMCH

Triangle Compounding Pharmacy

Peking University First Hospital

Affiliated Hospital of Guangdong Public Institution of Medicine

Lorraine's Pharmacy

PLAGH

Institutional Pharmacy Solutions

Ruijin Hospital

Belle Sante

Byculla Pharmacy&Stores

Royal Chemists

Village Compounding Pharmacy

Specialist Pharmacy

Compounding Pharmacy Segment by Type

PIA

PAA

CUPM

PDA

SAPM

Compounding Pharmacy Segment by Application

Consumers Aged 18 and Younger

Consumers Aged 19 to 44

Consumers Aged 45 to 64

Consumers Aged 65 and Older

Compounding Pharmacy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Compounding Pharmacy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Compounding Pharmacy key companies, revenue, market share, and recent developments.

3. To split the Compounding Pharmacy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Compounding Pharmacy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Compounding Pharmacy significant trends, drivers, influence factors in global and regions.

6. To analyze Compounding Pharmacy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounding Pharmacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Compounding Pharmacy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounding Pharmacy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Compounding Pharmacy industry.

Chapter 3: Detailed analysis of Compounding Pharmacy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Compounding Pharmacy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Compounding Pharmacy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Compounding Pharmacy Industry Trends Table 2. Compounding Pharmacy Industry Drivers Table 3. Compounding Pharmacy Industry Opportunities and Challenges Table 4. Compounding Pharmacy Industry Restraints Table 5. Global Compounding Pharmacy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Compounding Pharmacy Revenue Share by Company (2021-2026) Table 7. Global Compounding Pharmacy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Compounding Pharmacy Key Company Manufacturing Base & Headquarters Table 9. Global Compounding Pharmacy Company, Product Type & Application Table 10. Global Compounding Pharmacy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Compounding Pharmacy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of PIA Table 15. Significant Companies of PAA Table 16. Significant Companies of CUPM Table 17. Significant Companies of PDA Table 18. Significant Companies of SAPM Table 19. Global Compounding Pharmacy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Compounding Pharmacy Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Compounding Pharmacy Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Compounding Pharmacy Sales Value Share by Type (2021-2026) Table 23. Global Compounding Pharmacy Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Consumers Aged 18 and Younger Table 25. Significant Companies of Consumers Aged 19 to 44 Table 26. Significant Companies of Consumers Aged 45 to 64 Table 27. Significant Companies of Consumers Aged 65 and Older Table 28. Global Compounding Pharmacy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Compounding Pharmacy Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Compounding Pharmacy Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Compounding Pharmacy Sales Value Share by Application (2021-2026) Table 32. Global Compounding Pharmacy Sales Value Share by Application (2027-2032) Table 33. Global Compounding Pharmacy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Compounding Pharmacy Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Compounding Pharmacy Sales Value Share by Region (2021-2026) Table 36. Global Compounding Pharmacy Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Compounding Pharmacy Sales Value Share by Region (2027-2032) Table 38. Global Compounding Pharmacy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Compounding Pharmacy Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Compounding Pharmacy Sales Value Market Share by Country (2021-2026) Table 41. Global Compounding Pharmacy Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Compounding Pharmacy Sales Value Market Share by Country (2027-2032) Table 43. PharMEDium Services Company Information Table 44. PharMEDium Services Business Overview Table 45. PharMEDium Services Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. PharMEDium Services Compounding Pharmacy Product Portfolio Table 47. PharMEDium Services Recent Development Table 48. B. Braun Group Company Information Table 49. B. Braun Group Business Overview Table 50. B. Braun Group Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. B. Braun Group Compounding Pharmacy Product Portfolio Table 52. B. Braun Group Recent Development Table 53. Fagron Company Information Table 54. Fagron Business Overview Table 55. Fagron Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Fagron Compounding Pharmacy Product Portfolio Table 57. Fagron Recent Development Table 58. Wedgewood Pharmacy Company Information Table 59. Wedgewood Pharmacy Business Overview Table 60. Wedgewood Pharmacy Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Wedgewood Pharmacy Compounding Pharmacy Product Portfolio Table 62. Wedgewood Pharmacy Recent Development Table 63. New Compounding Pharma Company Information Table 64. New Compounding Pharma Business Overview Table 65. New Compounding Pharma Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. New Compounding Pharma Compounding Pharmacy Product Portfolio Table 67. New Compounding Pharma Recent Development Table 68. Medisca Company Information Table 69. Medisca Business Overview Table 70. Medisca Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Medisca Compounding Pharmacy Product Portfolio Table 72. Medisca Recent Development Table 73. Fresenius Kabi Company Information Table 74. Fresenius Kabi Business Overview Table 75. Fresenius Kabi Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Fresenius Kabi Compounding Pharmacy Product Portfolio Table 77. Fresenius Kabi Recent Development Table 78. Advanced Pharma Company Information Table 79. Advanced Pharma Business Overview Table 80. Advanced Pharma Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Advanced Pharma Compounding Pharmacy Product Portfolio Table 82. Advanced Pharma Recent Development Table 83. AIN GROUP Company Information Table 84. AIN GROUP Business Overview Table 85. AIN GROUP Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. AIN GROUP Compounding Pharmacy Product Portfolio Table 87. AIN GROUP Recent Development Table 88. Nihon Chouzai Company Information Table 89. Nihon Chouzai Business Overview Table 90. Nihon Chouzai Compounding Pharmacy Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Nihon Chouzai Compounding Pharmacy Product Portfolio Table 92. Nihon Chouzai Recent Development Table 93. Sogo Medical Company Information Table 94. Sogo Medical Business Overview Table 95. Sogo Medical Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Sogo Medical Compounding Pharmacy Product Portfolio Table 97. Sogo Medical Recent Development Table 98. Dougherty’s Pharmacy Company Information Table 99. Dougherty’s Pharmacy Business Overview Table 100. Dougherty’s Pharmacy Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Dougherty’s Pharmacy Compounding Pharmacy Product Portfolio Table 102. Dougherty’s Pharmacy Recent Development Table 103. Apollo Pharmacy Company Information Table 104. Apollo Pharmacy Business Overview Table 105. Apollo Pharmacy Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Apollo Pharmacy Compounding Pharmacy Product Portfolio Table 107. Apollo Pharmacy Recent Development Table 108. Downing Labs Company Information Table 109. Downing Labs Business Overview Table 110. Downing Labs Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Downing Labs Compounding Pharmacy Product Portfolio Table 112. Downing Labs Recent Development Table 113. Qol Holdings Company Information Table 114. Qol Holdings Business Overview Table 115. Qol Holdings Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Qol Holdings Compounding Pharmacy Product Portfolio Table 117. Qol Holdings Recent Development Table 118. Olympia Pharmacy Company Information Table 119. Olympia Pharmacy Business Overview Table 120. Olympia Pharmacy Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Olympia Pharmacy Compounding Pharmacy Product Portfolio Table 122. Olympia Pharmacy Recent Development Table 123. PUMCH Company Information Table 124. PUMCH Business Overview Table 125. PUMCH Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. PUMCH Compounding Pharmacy Product Portfolio Table 127. PUMCH Recent Development Table 128. Triangle Compounding Pharmacy Company Information Table 129. Triangle Compounding Pharmacy Business Overview Table 130. Triangle Compounding Pharmacy Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Triangle Compounding Pharmacy Compounding Pharmacy Product Portfolio Table 132. Triangle Compounding Pharmacy Recent Development Table 133. Peking University First Hospital Company Information Table 134. Peking University First Hospital Business Overview Table 135. Peking University First Hospital Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Peking University First Hospital Compounding Pharmacy Product Portfolio Table 137. Peking University First Hospital Recent Development Table 138. Affiliated Hospital of Guangdong Public Institution of Medicine Company Information Table 139. Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview Table 140. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product Portfolio Table 142. Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development Table 143. Lorraine's Pharmacy Company Information Table 144. Lorraine's Pharmacy Business Overview Table 145. Lorraine's Pharmacy Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 146. Lorraine's Pharmacy Compounding Pharmacy Product Portfolio Table 147. Lorraine's Pharmacy Recent Development Table 148. PLAGH Company Information Table 149. PLAGH Business Overview Table 150. PLAGH Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 151. PLAGH Compounding Pharmacy Product Portfolio Table 152. PLAGH Recent Development Table 153. Institutional Pharmacy Solutions Company Information Table 154. Institutional Pharmacy Solutions Business Overview Table 155. Institutional Pharmacy Solutions Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 156. Institutional Pharmacy Solutions Compounding Pharmacy Product Portfolio Table 157. Institutional Pharmacy Solutions Recent Development Table 158. Ruijin Hospital Company Information Table 159. Ruijin Hospital Business Overview Table 160. Ruijin Hospital Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 161. Ruijin Hospital Compounding Pharmacy Product Portfolio Table 162. Ruijin Hospital Recent Development Table 163. Belle Sante Company Information Table 164. Belle Sante Business Overview Table 165. Belle Sante Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 166. Belle Sante Compounding Pharmacy Product Portfolio Table 167. Belle Sante Recent Development Table 168. Byculla Pharmacy&Stores Company Information Table 169. Byculla Pharmacy&Stores Business Overview Table 170. Byculla Pharmacy&Stores Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 171. Byculla Pharmacy&Stores Compounding Pharmacy Product Portfolio Table 172. Byculla Pharmacy&Stores Recent Development Table 173. Royal Chemists Company Information Table 174. Royal Chemists Business Overview Table 175. Royal Chemists Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 176. Royal Chemists Compounding Pharmacy Product Portfolio Table 177. Royal Chemists Recent Development Table 178. Village Compounding Pharmacy Company Information Table 179. Village Compounding Pharmacy Business Overview Table 180. Village Compounding Pharmacy Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 181. Village Compounding Pharmacy Compounding Pharmacy Product Portfolio Table 182. Village Compounding Pharmacy Recent Development Table 183. Specialist Pharmacy Company Information Table 184. Specialist Pharmacy Business Overview Table 185. Specialist Pharmacy Compounding Pharmacy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 186. Specialist Pharmacy Compounding Pharmacy Product Portfolio Table 187. Specialist Pharmacy Recent Development Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Compounding Pharmacy Product Image Figure 2. Global Compounding Pharmacy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 4. Global Compounding Pharmacy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. PIA Image Figure 8. PAA Image Figure 9. CUPM Image Figure 10. PDA Image Figure 11. SAPM Image Figure 12. Global Compounding Pharmacy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Compounding Pharmacy Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Compounding Pharmacy Sales Value Share by Type (2021-2032) Figure 15. Consumers Aged 18 and Younger Image Figure 16. Consumers Aged 19 to 44 Image Figure 17. Consumers Aged 45 to 64 Image Figure 18. Consumers Aged 65 and Older Image Figure 19. Global Compounding Pharmacy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Compounding Pharmacy Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Compounding Pharmacy Sales Value Share by Application (2021-2032) Figure 22. Global Compounding Pharmacy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Compounding Pharmacy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Compounding Pharmacy Sales Value (2021-2032) & (US$ Million) Figure 25. North America Compounding Pharmacy Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Compounding Pharmacy Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Compounding Pharmacy Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Compounding Pharmacy Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Compounding Pharmacy Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Compounding Pharmacy Sales Value (2021-2032) & (US$ Million) Figure 31. South America Compounding Pharmacy Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Compounding Pharmacy Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Compounding Pharmacy Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Compounding Pharmacy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • PIA
  • PAA
  • CUPM
  • PDA
  • SAPM
Applications
  • Consumers Aged 18 and Younger
  • Consumers Aged 19 to 44
  • Consumers Aged 45 to 64
  • Consumers Aged 65 and Older
Companies covered
  • PharMEDium Services
  • B. Braun Group
  • Fagron
  • Wedgewood Pharmacy
  • New Compounding Pharma
  • Medisca
  • Fresenius Kabi
  • Advanced Pharma
  • AIN GROUP
  • Nihon Chouzai
  • Sogo Medical
  • Dougherty’s Pharmacy
  • Apollo Pharmacy
  • Downing Labs
  • Qol Holdings
  • Olympia Pharmacy
  • PUMCH
  • Triangle Compounding Pharmacy
  • Peking University First Hospital
  • Affiliated Hospital of Guangdong Public Institution of Medicine
  • Lorraine's Pharmacy
  • PLAGH
  • Institutional Pharmacy Solutions
  • Ruijin Hospital
  • Belle Sante
  • Byculla Pharmacy&Stores
  • Royal Chemists
  • Village Compounding Pharmacy
  • Specialist Pharmacy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Compounding Pharmacy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Compounding Pharmacy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Compounding Pharmacy Market Dynamics
  1. 2.1 Compounding Pharmacy Industry Trends
  2. 2.2 Compounding Pharmacy Industry Drivers
  3. 2.3 Compounding Pharmacy Industry Opportunities and Challenges
  4. 2.4 Compounding Pharmacy Industry Restraints
3 Compounding Pharmacy Market by Company
  1. 3.1 Global Compounding Pharmacy Company Revenue Ranking in 2025
  2. 3.2 Global Compounding Pharmacy Revenue by Company (2021-2026)
  3. 3.3 Global Compounding Pharmacy Company Ranking (2024-2026)
  4. 3.4 Global Compounding Pharmacy Company Manufacturing Base and Headquarters
  5. 3.5 Global Compounding Pharmacy Company Product Type and Application
  6. 3.6 Global Compounding Pharmacy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Compounding Pharmacy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Compounding Pharmacy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Compounding Pharmacy Market by Type
  1. 4.1 Compounding Pharmacy Type Introduction
  2. 4.1.1 PIA
  3. 4.1.2 PAA
  4. 4.1.3 CUPM
  5. 4.1.4 PDA
  6. 4.1.5 SAPM
  7. 4.2 Global Compounding Pharmacy Sales Value by Type
  8. 4.2.1 Global Compounding Pharmacy Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Compounding Pharmacy Sales Value by Type (2021-2032)
  10. 4.2.3 Global Compounding Pharmacy Sales Value Share by Type (2021-2032)
5 Compounding Pharmacy Market by Application
  1. 5.1 Compounding Pharmacy Application Introduction
  2. 5.1.1 Consumers Aged 18 and Younger
  3. 5.1.2 Consumers Aged 19 to 44
  4. 5.1.3 Consumers Aged 45 to 64
  5. 5.1.4 Consumers Aged 65 and Older
  6. 5.2 Global Compounding Pharmacy Sales Value by Application
  7. 5.2.1 Global Compounding Pharmacy Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Compounding Pharmacy Sales Value by Application (2021-2032)
  9. 5.2.3 Global Compounding Pharmacy Sales Value Share by Application (2021-2032)
6 Compounding Pharmacy Regional Value Analysis
  1. 6.1 Global Compounding Pharmacy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Compounding Pharmacy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Compounding Pharmacy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Compounding Pharmacy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Compounding Pharmacy Sales Value (2021-2032)
  7. 6.3.2 North America Compounding Pharmacy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Compounding Pharmacy Sales Value (2021-2032)
  10. 6.4.2 Europe Compounding Pharmacy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Compounding Pharmacy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Compounding Pharmacy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Compounding Pharmacy Sales Value (2021-2032)
  16. 6.6.2 South America Compounding Pharmacy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Compounding Pharmacy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Compounding Pharmacy Sales Value Share by Country, 2025 VS 2032
7 Compounding Pharmacy Country-level Value Analysis
  1. 7.1 Global Compounding Pharmacy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Compounding Pharmacy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Compounding Pharmacy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Compounding Pharmacy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Compounding Pharmacy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Compounding Pharmacy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Compounding Pharmacy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 PharMEDium Services
  2. 8.1.1 PharMEDium Services Company Information
  3. 8.1.2 PharMEDium Services Business Overview
  4. 8.1.3 PharMEDium Services Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 PharMEDium Services Compounding Pharmacy Product Portfolio
  6. 8.1.5 PharMEDium Services Recent Developments
  7. 8.2 B. Braun Group
  8. 8.2.1 B. Braun Group Company Information
  9. 8.2.2 B. Braun Group Business Overview
  10. 8.2.3 B. Braun Group Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 B. Braun Group Compounding Pharmacy Product Portfolio
  12. 8.2.5 B. Braun Group Recent Developments
  13. 8.3 Fagron
  14. 8.3.1 Fagron Company Information
  15. 8.3.2 Fagron Business Overview
  16. 8.3.3 Fagron Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fagron Compounding Pharmacy Product Portfolio
  18. 8.3.5 Fagron Recent Developments
  19. 8.4 Wedgewood Pharmacy
  20. 8.4.1 Wedgewood Pharmacy Company Information
  21. 8.4.2 Wedgewood Pharmacy Business Overview
  22. 8.4.3 Wedgewood Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wedgewood Pharmacy Compounding Pharmacy Product Portfolio
  24. 8.4.5 Wedgewood Pharmacy Recent Developments
  25. 8.5 New Compounding Pharma
  26. 8.5.1 New Compounding Pharma Company Information
  27. 8.5.2 New Compounding Pharma Business Overview
  28. 8.5.3 New Compounding Pharma Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 New Compounding Pharma Compounding Pharmacy Product Portfolio
  30. 8.5.5 New Compounding Pharma Recent Developments
  31. 8.6 Medisca
  32. 8.6.1 Medisca Company Information
  33. 8.6.2 Medisca Business Overview
  34. 8.6.3 Medisca Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medisca Compounding Pharmacy Product Portfolio
  36. 8.6.5 Medisca Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Compounding Pharmacy Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
  43. 8.8 Advanced Pharma
  44. 8.8.1 Advanced Pharma Company Information
  45. 8.8.2 Advanced Pharma Business Overview
  46. 8.8.3 Advanced Pharma Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Advanced Pharma Compounding Pharmacy Product Portfolio
  48. 8.8.5 Advanced Pharma Recent Developments
  49. 8.9 AIN GROUP
  50. 8.9.1 AIN GROUP Company Information
  51. 8.9.2 AIN GROUP Business Overview
  52. 8.9.3 AIN GROUP Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AIN GROUP Compounding Pharmacy Product Portfolio
  54. 8.9.5 AIN GROUP Recent Developments
  55. 8.10 Nihon Chouzai
  56. 8.10.1 Nihon Chouzai Company Information
  57. 8.10.2 Nihon Chouzai Business Overview
  58. 8.10.3 Nihon Chouzai Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nihon Chouzai Compounding Pharmacy Product Portfolio
  60. 8.10.5 Nihon Chouzai Recent Developments
  61. 8.11 Sogo Medical
  62. 8.11.1 Sogo Medical Company Information
  63. 8.11.2 Sogo Medical Business Overview
  64. 8.11.3 Sogo Medical Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sogo Medical Compounding Pharmacy Product Portfolio
  66. 8.11.5 Sogo Medical Recent Developments
  67. 8.12 Dougherty’s Pharmacy
  68. 8.12.1 Dougherty’s Pharmacy Company Information
  69. 8.12.2 Dougherty’s Pharmacy Business Overview
  70. 8.12.3 Dougherty’s Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dougherty’s Pharmacy Compounding Pharmacy Product Portfolio
  72. 8.12.5 Dougherty’s Pharmacy Recent Developments
  73. 8.13 Apollo Pharmacy
  74. 8.13.1 Apollo Pharmacy Company Information
  75. 8.13.2 Apollo Pharmacy Business Overview
  76. 8.13.3 Apollo Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Apollo Pharmacy Compounding Pharmacy Product Portfolio
  78. 8.13.5 Apollo Pharmacy Recent Developments
  79. 8.14 Downing Labs
  80. 8.14.1 Downing Labs Company Information
  81. 8.14.2 Downing Labs Business Overview
  82. 8.14.3 Downing Labs Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Downing Labs Compounding Pharmacy Product Portfolio
  84. 8.14.5 Downing Labs Recent Developments
  85. 8.15 Qol Holdings
  86. 8.15.1 Qol Holdings Company Information
  87. 8.15.2 Qol Holdings Business Overview
  88. 8.15.3 Qol Holdings Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Qol Holdings Compounding Pharmacy Product Portfolio
  90. 8.15.5 Qol Holdings Recent Developments
  91. 8.16 Olympia Pharmacy
  92. 8.16.1 Olympia Pharmacy Company Information
  93. 8.16.2 Olympia Pharmacy Business Overview
  94. 8.16.3 Olympia Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Olympia Pharmacy Compounding Pharmacy Product Portfolio
  96. 8.16.5 Olympia Pharmacy Recent Developments
  97. 8.17 PUMCH
  98. 8.17.1 PUMCH Company Information
  99. 8.17.2 PUMCH Business Overview
  100. 8.17.3 PUMCH Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  101. 8.17.4 PUMCH Compounding Pharmacy Product Portfolio
  102. 8.17.5 PUMCH Recent Developments
  103. 8.18 Triangle Compounding Pharmacy
  104. 8.18.1 Triangle Compounding Pharmacy Company Information
  105. 8.18.2 Triangle Compounding Pharmacy Business Overview
  106. 8.18.3 Triangle Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Triangle Compounding Pharmacy Compounding Pharmacy Product Portfolio
  108. 8.18.5 Triangle Compounding Pharmacy Recent Developments
  109. 8.19 Peking University First Hospital
  110. 8.19.1 Peking University First Hospital Company Information
  111. 8.19.2 Peking University First Hospital Business Overview
  112. 8.19.3 Peking University First Hospital Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Peking University First Hospital Compounding Pharmacy Product Portfolio
  114. 8.19.5 Peking University First Hospital Recent Developments
  115. 8.20 Affiliated Hospital of Guangdong Public Institution of Medicine
  116. 8.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine Company Information
  117. 8.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
  118. 8.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product Portfolio
  120. 8.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine Recent Developments
  121. 8.21 Lorraine's Pharmacy
  122. 8.21.1 Lorraine's Pharmacy Company Information
  123. 8.21.2 Lorraine's Pharmacy Business Overview
  124. 8.21.3 Lorraine's Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Lorraine's Pharmacy Compounding Pharmacy Product Portfolio
  126. 8.21.5 Lorraine's Pharmacy Recent Developments
  127. 8.22 PLAGH
  128. 8.22.1 PLAGH Company Information
  129. 8.22.2 PLAGH Business Overview
  130. 8.22.3 PLAGH Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  131. 8.22.4 PLAGH Compounding Pharmacy Product Portfolio
  132. 8.22.5 PLAGH Recent Developments
  133. 8.23 Institutional Pharmacy Solutions
  134. 8.23.1 Institutional Pharmacy Solutions Company Information
  135. 8.23.2 Institutional Pharmacy Solutions Business Overview
  136. 8.23.3 Institutional Pharmacy Solutions Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Institutional Pharmacy Solutions Compounding Pharmacy Product Portfolio
  138. 8.23.5 Institutional Pharmacy Solutions Recent Developments
  139. 8.24 Ruijin Hospital
  140. 8.24.1 Ruijin Hospital Company Information
  141. 8.24.2 Ruijin Hospital Business Overview
  142. 8.24.3 Ruijin Hospital Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Ruijin Hospital Compounding Pharmacy Product Portfolio
  144. 8.24.5 Ruijin Hospital Recent Developments
  145. 8.25 Belle Sante
  146. 8.25.1 Belle Sante Company Information
  147. 8.25.2 Belle Sante Business Overview
  148. 8.25.3 Belle Sante Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Belle Sante Compounding Pharmacy Product Portfolio
  150. 8.25.5 Belle Sante Recent Developments
  151. 8.26 Byculla Pharmacy&Stores
  152. 8.26.1 Byculla Pharmacy&Stores Company Information
  153. 8.26.2 Byculla Pharmacy&Stores Business Overview
  154. 8.26.3 Byculla Pharmacy&Stores Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Byculla Pharmacy&Stores Compounding Pharmacy Product Portfolio
  156. 8.26.5 Byculla Pharmacy&Stores Recent Developments
  157. 8.27 Royal Chemists
  158. 8.27.1 Royal Chemists Company Information
  159. 8.27.2 Royal Chemists Business Overview
  160. 8.27.3 Royal Chemists Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Royal Chemists Compounding Pharmacy Product Portfolio
  162. 8.27.5 Royal Chemists Recent Developments
  163. 8.28 Village Compounding Pharmacy
  164. 8.28.1 Village Compounding Pharmacy Company Information
  165. 8.28.2 Village Compounding Pharmacy Business Overview
  166. 8.28.3 Village Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Village Compounding Pharmacy Compounding Pharmacy Product Portfolio
  168. 8.28.5 Village Compounding Pharmacy Recent Developments
  169. 8.29 Specialist Pharmacy
  170. 8.29.1 Specialist Pharmacy Company Information
  171. 8.29.2 Specialist Pharmacy Business Overview
  172. 8.29.3 Specialist Pharmacy Compounding Pharmacy Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Specialist Pharmacy Compounding Pharmacy Product Portfolio
  174. 8.29.5 Specialist Pharmacy Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst